Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Prokineticin-2 (PK2) is a secreted protein involved in a number of physiological functions. Here, the authors find that PK2 expression increases in surviving DA neurons from Parkinson's disease patients, and show it protects against dopaminergic degeneration in PD mouse models.
Enregistré dans:
Auteurs principaux: | Richard Gordon, Matthew L. Neal, Jie Luo, Monica R. Langley, Dilshan S. Harischandra, Nikhil Panicker, Adhithiya Charli, Huajun Jin, Vellareddy Anantharam, Trent M. Woodruff, Qun-Yong Zhou, Anumantha G. Kanthasamy, Arthi Kanthasamy |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b8d6e03a18c04bd3a3c79b515e12e20f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
par: Zhongyuan Bao, et autres
Publié: (2021) -
Prokineticin receptor 2 affects GnRH3 neuron ontogeny but not fertility in zebrafish
par: Ivan Bassi, et autres
Publié: (2020) -
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
par: Roberta Lattanzi, et autres
Publié: (2021) -
PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
par: Sarah J. Brown, et autres
Publié: (2021) -
Prokineticin 1–prokineticin receptor 1 signaling in trophoblast promotes embryo implantation and placenta development
par: Ewelina Goryszewska-Szczurek, et autres
Publié: (2021)